Jackson Acquisition Co II (NASDAQ: JACS) is a blank check special purpose acquisition company incorporated on September 11, 2024, as a Cayman Islands exempted company, formed for the purpose of completing a merger, share exchange, asset acquisition, share purchase, recapitalization, or similar business combination with one or more businesses. The company generates no operating revenue; its capital base derives from its IPO, which closed on December 11, 2024, raising $230,000,000 in gross proceeds through the sale of 23,000,000 units at $10.00 per unit. JACS intends to focus its acquisition search on healthcare services, healthcare technology, or businesses otherwise concentrated in the healthcare industry. The sponsor is RJ Healthcare SPAC II, LLC, and executive offices are located in Alpharetta, GA. Richard L. Jackson serves as Chief Executive Officer and David Lawrence as Chief Financial Officer, as of the 10-K filed March 20, 2026. The company must complete an initial business combination by December 11, 2026, or redeem public shares from the trust account.

Revenue model

No operating revenue. Capital is held in a trust account funded by IPO proceeds of $230,000,000 (gross, closed December 11, 2024). Returns to shareholders depend on completing an initial business combination or redemption of public shares.

Products and services

Blank check SPAC vehicle. Each IPO unit consists of one Class A ordinary share ($0.0001 par value) and one right to receive one-tenth of one Class A ordinary share upon completion of the initial business combination. Units were sold at $10.00 each.

Customers and end markets

Target acquisition sectors: healthcare services, healthcare technology, and healthcare-adjacent businesses. Public shareholders hold Class A ordinary shares with redemption rights tied to the initial business combination deadline of December 11, 2026.

Value-chain role

Acquisition vehicle. JACS identifies, evaluates, and executes a business combination with a private target, providing that target access to public capital markets. The sponsor, RJ Healthcare SPAC II, LLC, holds founder shares classified as Class B ordinary shares.

Geographic exposure

Incorporated in the Cayman Islands. Executive offices in Alpharetta, GA 30009. Acquisition targets may be in any industry or geographic location, with stated focus on healthcare.

Source: SEC 10-K, filed 2026-03-20

Industry: Blank Checks